Literature DB >> 34052101

Cyclin E in normal physiology and disease states.

Chen Chu1, Yan Geng1, Yu Zhou2, Piotr Sicinski3.   

Abstract

E-type cyclins, collectively called cyclin E, represent key components of the core cell cycle machinery. In mammalian cells, two E-type cyclins, E1 and E2, activate cyclin-dependent kinase 2 (CDK2) and drive cell cycle progression by phosphorylating several cellular proteins. Abnormally elevated activity of cyclin E-CDK2 has been documented in many human tumor types. Moreover, cyclin E overexpression mediates resistance of tumor cells to various therapeutic agents. Recent work has revealed that the role of cyclin E extends well beyond cell proliferation and tumorigenesis, and it may regulate a diverse array of physiological and pathological processes. In this review, we discuss these various cyclin E functions and the potential for therapeutic targeting of cyclin E and cyclin E-CDK2 kinase.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CDK2; cancer; cell cycle; cyclin E; cyclin-dependent kinases

Mesh:

Substances:

Year:  2021        PMID: 34052101      PMCID: PMC8364501          DOI: 10.1016/j.tcb.2021.05.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   21.167


  102 in total

Review 1.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

2.  An integrated view of cyclin E function and regulation.

Authors:  Ka Tat Siu; Marsha Rich Rosner; Alex C Minella
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

3.  Cyclin E is expressed in neurons and forms complexes with cdk5.

Authors:  M Miyajima; H O Nornes; T Neuman
Journal:  Neuroreport       Date:  1995-05-30       Impact factor: 1.837

4.  Rescue of cyclin D1 deficiency by knockin cyclin E.

Authors:  Y Geng; W Whoriskey; M Y Park; R T Bronson; R H Medema; T Li; R A Weinberg; P Sicinski
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

5.  Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.

Authors:  J G Mussman; H F Horn; P E Carroll; M Okuda; P Tarapore; L A Donehower; K Fukasawa
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

6.  Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.

Authors:  Yan Ma; Steven Fiering; Candice Black; Xi Liu; Ziqiang Yuan; Vincent A Memoli; David J Robbins; Heather A Bentley; Gregory J Tsongalis; Eugene Demidenko; Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

7.  Cyclin E as a coactivator of the androgen receptor.

Authors:  A Yamamoto; Y Hashimoto; K Kohri; E Ogata; S Kato; K Ikeda; M Nakanishi
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

8.  Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo.

Authors:  Junko Odajima; Siddharth Saini; Piotr Jung; Yasmine Ndassa-Colday; Scott Ficaro; Yan Geng; Eugenio Marco; Wojciech Michowski; Yaoyu E Wang; James A DeCaprio; Larisa Litovchick; Jarrod Marto; Piotr Sicinski
Journal:  PLoS Genet       Date:  2016-11-09       Impact factor: 5.917

9.  Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.

Authors:  Maurizio Scaltriti; Pieter J Eichhorn; Javier Cortés; Ludmila Prudkin; Claudia Aura; José Jiménez; Sarat Chandarlapaty; Violeta Serra; Aleix Prat; Yasir H Ibrahim; Marta Guzmán; Magui Gili; Olga Rodríguez; Sonia Rodríguez; José Pérez; Simon R Green; Sabine Mai; Neal Rosen; Clifford Hudis; José Baselga
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

10.  The requirement for cyclin E in c-Myc overexpressing breast cancers.

Authors:  Yu Zhou; Yan Geng; Yujiao Zhang; Yubin Zhou; Chen Chu; Samanta Sharma; Anne Fassl; Deborah Butter; Piotr Sicinski
Journal:  Cell Cycle       Date:  2020-09-25       Impact factor: 4.534

View more
  11 in total

1.  Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.

Authors:  Márk Híveš; Jana Jurečeková; Ján Kliment; Marián Grendár; Peter Kaplán; Róbert Dušenka; Daniel Evin; Marta Vilčková; Klaudia Híveš Holečková; Monika Kmeťová Sivoňová
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

2.  Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.

Authors:  Jia Gu; Neng Zhu; Hong-Fang Li; Tan-Jun Zhao; Chan-Juan Zhang; Duan-Fang Liao; Li Qin
Journal:  Cell Oncol (Dordr)       Date:  2022-07-22       Impact factor: 7.051

3.  Disruption of Toxoplasma gondii-Induced Host Cell DNA Replication Is Dependent on Contact Inhibition and Host Cell Type.

Authors:  Edwin Pierre-Louis; Menna G Etheridge; Rodrigo de Paula Baptista; Asis Khan; Nathan M Chasen; Ronald D Etheridge
Journal:  mSphere       Date:  2022-05-19       Impact factor: 5.029

4.  The Potential Key Role of the NRF2/NQO1 Pathway in the Health Effects of Arsenic Pollution on SCC.

Authors:  Qianlei Yang; Rui Yan; Yuemei Mo; Haixuan Xia; Hanyi Deng; Xiaojuan Wang; Chunchun Li; Koichi Kato; Hengdong Zhang; Tingxu Jin; Jie Zhang; Yan An
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

5.  Phosphorylation of RNA Polymerase II by CDKC;2 Maintains the Arabidopsis Circadian Clock Period.

Authors:  Takahiro N Uehara; Takashi Nonoyama; Kyomi Taki; Keiko Kuwata; Ayato Sato; Kazuhiro J Fujimoto; Tsuyoshi Hirota; Hiromi Matsuo; Akari E Maeda; Azusa Ono; Tomoaki T Takahara; Hiroki Tsutsui; Takamasa Suzuki; Takeshi Yanai; Steve A Kay; Kenichiro Itami; Toshinori Kinoshita; Junichiro Yamaguchi; Norihito Nakamichi
Journal:  Plant Cell Physiol       Date:  2022-04-19       Impact factor: 4.937

6.  CCNE1 and E2F1 Partially Suppress G1 Phase Arrest Caused by Spliceostatin A Treatment.

Authors:  Kei Kikuchi; Daisuke Kaida
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 7.  Emerging Mechanisms of G1/S Cell Cycle Control by Human and Mouse Cytomegaloviruses.

Authors:  Boris Bogdanow; Quang Vinh Phan; Lüder Wiebusch
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.867

8.  Quantitative profiling of adaptation to cyclin E overproduction.

Authors:  Juanita C Limas; Amiee N Littlejohn; Amy M House; Katarzyna M Kedziora; Brandon L Mouery; Boyang Ma; Dalia Fleifel; Andrea Walens; Maria M Aleman; Daniel Dominguez; Jeanette Gowen Cook
Journal:  Life Sci Alliance       Date:  2022-02-16

9.  Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1.

Authors:  Ihiro Endo; Vishwa Jeet Amatya; Kei Kushitani; Takahiro Kambara; Tetsuya Nakagiri; Yutaro Fujii; Yukio Takeshima
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

Review 10.  Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability.

Authors:  Rafaela Fagundes; Leonardo K Teixeira
Journal:  Front Cell Dev Biol       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.